Pain as a presenting symptom in children and young adults with newly diagnosed malignancy.

Pain

Pediatric Branch, National Cancer Institute, Bethesda, MD 20892 U.S.A. Biostatistics and Data Management Section, National Cancer Institute, Bethesda, MD 20892 U.S.A. Cancer Nursing Service, Clinical Center, National Institutes of Health, Bethesda, MD 20892 U.S.A.

Published: April 1987

The incidence and nature of pain in 92 children and young adults presenting with newly diagnosed malignancy at the Pediatric Branch of the National Cancer Institute over a 26 month period were assessed. At the time of their initial evaluation, 72 of the total 92 patients were experiencing pain that had been present for a median of 74 days (range 3-821 days) prior to initiation of cancer treatment. In 57 patients, pain had been an initial symptom of cancer; 42 patients had experienced sleep disturbance due to pain. Following the institution of cancer therapy, pain persisted for a median of 10 days. One patient died of malignancy after 5 months without resolution of her pain, and only 4 had persistent pain for greater than 9 months after the start of treatment. Persistent pain is an important symptom of cancer in children and young adults and is often present for long periods before the diagnosis of malignancy is made. Cancer in children usually responds rapidly to modern therapy, and pain usually persists only briefly after the initiation of treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0304-3959(87)90181-3DOI Listing

Publication Analysis

Top Keywords

children young
12
young adults
12
pain
10
newly diagnosed
8
diagnosed malignancy
8
median days
8
symptom cancer
8
therapy pain
8
persistent pain
8
cancer children
8

Similar Publications

Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders.

Neurol Neuroimmunol Neuroinflamm

March 2025

Neuroimmunology Laboratory and Neuroimmunology Research Section, IRCCS Mondino Foundation, Pavia, Italy.

Background And Objectives: Antibodies to proteolipid protein-1 (PLP1-IgG), a major central myelin protein also expressed in the peripheral nervous system (PNS) as the isoform DM20, have been previously identified mostly in patients with multiple sclerosis (MS), with unclear clinical implications. However, most studies relied on nonconformational immunoassays and included few patients with non-MS CNS autoimmune demyelinating disorders (ADDs). We aimed to investigate conformational PLP1-IgG in the whole ADD spectrum.

View Article and Find Full Text PDF

Background And Objectives: While it is well characterized in adults, little is known about the clinical features of neurofascin 155-IgG4 autoimmune nodopathy (NF155-IgG4 AN) in the pediatric population. In this study, we aimed to describe the clinical features and treatment outcomes in children diagnosed with neurofascin 155-IgG4 autoimmune nodopathy (NF155-IgG4 AN).

Methods: Pediatric and adult patients with NF155-IgG4 AN were identified retrospectively through the Mayo Clinic Neuroimmunology Laboratory database.

View Article and Find Full Text PDF

Introduction: Children growing up in arid and semi-arid regions of Sub-Saharan Africa (SSA) face heightened risks, often resulting in poor developmental outcomes. In Kenya, the arid and semi-arid lands (ASAL) exhibit the lowest health and developmental indicators among children. Despite these risks, some children grow up successfully and overcome the challenges.

View Article and Find Full Text PDF

Introduction: The prevalence of epilepsy in sub-Saharan Africa varies considerably, and the exact estimate for Ghana remains unclear, particularly in peri-urban areas where data are scarce. More community-based studies are required to understand better the actual burden of epilepsy in these areas and the difficulties in accessing healthcare.

Objective: To adapt and validate a household survey epilepsy-screening instrument in Shai-Osudoku and Ningo-Prampram District of Greater Accra Region, Ghana.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!